Alexander Tsodikov

Affiliations: 
University of California, Davis, Davis, CA 
Area:
Statistics
Google:
"Alexander Tsodikov"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chao YC, Tran Q, Tsodikov A, et al. (2020) Joint modeling and multiple comparisons with the best of data from a SMART with survival outcomes. Biostatistics (Oxford, England)
Heijnsdijk EAM, Gulati R, Tsodikov A, et al. (2020) Lifetime benefits and harms of PSA-based risk screening for prostate cancer. Journal of the National Cancer Institute
Suresh K, Taylor JMG, Tsodikov A. (2019) A Gaussian copula approach for dynamic prediction of survival with a longitudinal biomarker. Biostatistics (Oxford, England)
Chapman CH, Caram MEV, Radhakrishnan A, et al. (2019) Association between PSA values and surveillance quality after prostate cancer surgery. Cancer Medicine
Wang S, Tsodikov A. (2019) A Self-consistency Approach to Multinomial Logit Model with Random Effects. Journal of Statistical Planning and Inference. 140: 1939-1947
Skolarus TA, Caram ME, Chapman CH, et al. (2018) Castration Remains Despite Decreasing Definitive Treatment of Localized Prostate Cancer in the Elderly: A Case for De-Implementation. Cancer
Chapman CH, Burns J, Tsodikov A, et al. (2018) Clinical Predictors and Disparities in Surveillance PSA Utilization after Prostate Cancer Treatment International Journal of Radiation Oncology Biology Physics. 102
de Koning HJ, Gulati R, Moss SM, et al. (2017) The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials. Cancer
Tran Q, Kidwell KM, Tsodikov A. (2017) A joint model of cancer incidence, metastasis, and mortality. Lifetime Data Analysis
Tsodikov A, Gulati R, Heijnsdijk EAM, et al. (2017) Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials. Annals of Internal Medicine
See more...